138 related articles for article (PubMed ID: 9111190)
1. Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats.
Sweeney LM; Schlosser PM; Medinsky MA; Bond JA
Carcinogenesis; 1997 Apr; 18(4):611-25. PubMed ID: 9111190
[TBL] [Abstract][Full Text] [Related]
2. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
Bond JA; Recio L; Andjelkovich D
Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
[TBL] [Abstract][Full Text] [Related]
5. In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data.
Medinsky MA; Leavens TL; Csanády GA; Gargas ML; Bond JA
Carcinogenesis; 1994 Jul; 15(7):1329-40. PubMed ID: 8033308
[TBL] [Abstract][Full Text] [Related]
6. Micronuclei and gene mutations in transgenic big Blue((R)) mouse and rat fibroblasts after exposure to the epoxide metabolites of 1, 3-butadiene.
Erexson GL; Tindall KR
Mutat Res; 2000 Dec; 472(1-2):105-17. PubMed ID: 11113703
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
8. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
Himmelstein MW; Asgharian B; Bond JA
Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
[TBL] [Abstract][Full Text] [Related]
9. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.
Johanson G; Filser JG
Arch Toxicol; 1993; 67(3):151-63. PubMed ID: 8494494
[TBL] [Abstract][Full Text] [Related]
10. Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues.
Brochot C; Smith TJ; Bois FY
Chem Biol Interact; 2007 May; 167(3):168-83. PubMed ID: 17397815
[TBL] [Abstract][Full Text] [Related]
11. A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts--relevance of glutathione depletion.
Csanády GA; Kreuzer PE; Baur C; Filser JG
Toxicology; 1996 Oct; 113(1-3):300-5. PubMed ID: 8901913
[TBL] [Abstract][Full Text] [Related]
12. Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro.
Boogaard PJ; Sumner SC; Bond JA
Toxicol Appl Pharmacol; 1996 Feb; 136(2):307-16. PubMed ID: 8619238
[TBL] [Abstract][Full Text] [Related]
13. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
Seaton MJ; Follansbee MH; Bond JA
Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
[TBL] [Abstract][Full Text] [Related]
14. Disposition of butadiene epoxides in Sprague-Dawley rats.
Valentine JL; Boogaard PJ; Sweeney LM; Turner MJ; Bond JA; Medinsky MA
Chem Biol Interact; 1997 May; 104(2-3):103-15. PubMed ID: 9212778
[TBL] [Abstract][Full Text] [Related]
15. Genetic effects of 1,3-butadiene and associated risk for heritable damage.
Pacchierotti F; Adler ID; Anderson D; Brinkworth M; Demopoulos NA; Lähdetie J; Osterman-Golkar S; Peltonen K; Russo A; Tates A; Waters R
Mutat Res; 1998 Jan; 397(1):93-115. PubMed ID: 9463556
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Toxicology; 1996 Oct; 113(1-3):306-9. PubMed ID: 8901914
[TBL] [Abstract][Full Text] [Related]
17. 1,3-Butadiene metabolism by lung airways isolated from mice and rats.
Seaton MJ; Plopper CG; Bond JA
Toxicology; 1996 Oct; 113(1-3):314-7. PubMed ID: 8901916
[TBL] [Abstract][Full Text] [Related]
18. Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control.
Kohn MC; Melnick RL
Carcinogenesis; 1993 Apr; 14(4):619-28. PubMed ID: 8472325
[TBL] [Abstract][Full Text] [Related]
19. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
[TBL] [Abstract][Full Text] [Related]
20. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment.
Sweeney LM; Himmelstein MW; Gargas ML
Chem Biol Interact; 2001 Jun; 135-136():303-22. PubMed ID: 11397398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]